For example, a study involving GENFI and another genetic FTD cohort has recently shown that mutation carriers whose score worsens on the CDR+NACC FTLD over the next 1–2 years have high plasma neurofilament light chain concentrations at baseline compared with non-converters.32 The gene discussed is NEFL; the disease is frontotemporal dementia.